📰 Lapam Capital News
Lapam Capital News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Lapam Capital. Real-time updates on events, politics, business and more.
March 12, 2024
Semiconductor firm Juexin Microelectronics has notched 500 million yuan ($70.5 million) in a fresh funding round to expand its production facility.
November 21, 2022
Shanghai Fosun Pharma announced it has licensed US rights to a PD-1 candidate from its longstanding partner Henlius Biotech in an $840 million agreement. Read more here...
September 29, 2022
/PRNewswire/ -- NeuShen Therapeutics, Inc., a biotechnology company focusing on developing innovative treatments for central nervous system (CNS) disorders...
July 28, 2022
BridGene has raised $38.5m in Series B financing round to develop its chemoproteomic platform, IMTAC, as well as oncology drugs.
July 28, 2022
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
July 27, 2022
/PRNewswire/ -- BridGene Biosciences, Inc., a biotechnology company leveraging a proprietary chemoproteomic platform to discover and develop small-molecule...
October 12, 2021
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
August 20, 2021
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
June 3, 2021
Sequoia China co-leads $188m round in Covid vaccine developer Stemirna Photo: National Cancer Institute/Unsplash June 3, 2021 mRNA driven drugs and vaccines maker Stemirna Therapeutics on Thursday announced that it has raked in 1.2 billion yuan ($188 million) in a new funding round jointly led by Sequoia Capital China, state-backed China Merchants Medical and Healthcare Industry Equity Fund, Chinese global pharma major WuXi AppTec and Greenwoods Investment. The round also saw participation fr...